Monday, July 28, 2014 9:00:21 PM
You still don't get it. He had to disgorge those funds back to the company BY LAW. He didn't do so because of the way "others felt" or out of the goodness of his heart or for any reason other than to comply with securities regulations.....regulations that he should have been aware of prior to entering into the violative transaction. I made no judgment regarding a conflict of interest, merely providing the facts which were, and appear still to be, misunderstood.
"I am well researched concerning proceedings concerning the purchase of the lab by NNVC."
Your post certainly didn't suggest that or I would not have felt a need to provide the link to the company's statement.
You quoted a previous poster who said "The word is NNVC is going to buy Diwan's lab (most of which was built on sale of NNVC stock selling on open market lowering NNVC's value by 50%)."
And then responded to them, saying:
"Where did you hear the word? All news to me."
If you weren't saying that you weren't aware that NNVC was going to buy Diwan's lab, then just what was "All news to me"?
You needn't respond. Or read my posts. It's okay. Both of my pickings and choosings were only meant to be informative.
"I ated the purple berries"
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM